Siren Fund Invests $75 Million in Hair Loss Biotech Stock Veradermics Post-IPO Surge
On May 14, 2026, Siren disclosed a new position of over 1.5 million shares in Veradermics (NYSE:MANE), valued at approximately $75.94 million based on quarterly average pricing. The stock has surged more than 500% since its February IPO and is now trading near $107, with the stake's value reaching an estimated $95.06 million.
Topics: biotech hair loss treatment SEC filing stock investment